Atorvastatin 10 mg

DRUG5 trials

Sponsors

Organon and Co, Ohio State University

Conditions

Coronary ArteriosclerosisGestational HypertensionHypercholesterolemiaHypertensive Disorders of PregnancyPreeclampsia

Phase 3

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

CompletedNCT00535405

Organon and CoHypercholesterolemia

Start: 2007-11-30End: 2009-03-31Updated: 2024-05-16

A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)

CompletedNCT02550288

Organon and CoHypercholesterolemia

Start: 2015-09-29End: 2016-05-30Updated: 2024-05-16

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

CompletedNCT03867110

Organon and CoHypercholesterolemia

Start: 2000-03-06End: 2001-07-27Updated: 2024-05-10

Phase 4

Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

CompletedNCT00319449

Organon and CoCoronary Arteriosclerosis, Hypercholesterolemia

Start: 2005-09-30End: 2006-10-31Updated: 2022-02-09

AtorvaStatin Postpartum and Reduction of Cardiovascular risK

RecruitingNCT06632379

Ohio State UniversityGestational Hypertension, Hypertensive Disorders of Pregnancy, Preeclampsia

Start: 2025-10-03End: 2026-12-15Target: 76Updated: 2025-10-17